Characterization of Methylthioadenosin Phosphorylase (MTAP) Expression in Malignant Melanoma
- 31 August 2003
- journal article
- Published by Elsevier
- Vol. 163 (2) , 683-690
- https://doi.org/10.1016/s0002-9440(10)63695-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line.2002
- Adjuvant therapy for patients with high-risk malignant melanomaSeminars in Oncology, 2002
- Interferon Alfa Therapy for Malignant Melanoma: A Systematic Review of Randomized Controlled TrialsJournal of Clinical Oncology, 2002
- Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.2002
- Loss of p14ARF expression in melanomaArchives of Dermatological Research, 2001
- Detection of invasion-related chromosomal changes in highly and weakly invasive melanoma cell clones by a modified comparative genomic hybridization approachMelanoma Research, 2001
- Arginine Methylation of STAT1 Modulates IFNα/β-Induced TranscriptionCell, 2001
- Loss of E-cadherin Expression in Melanoma Cells Involves Up-regulation of the Transcriptional Repressor SnailJournal of Biological Chemistry, 2001
- In vitro modulation of human melanoma cell invasion and proliferation by all-frans-retinoic acidMelanoma Research, 1998
- Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancerVirchows Archiv, 1986